1. Cancer stem cells and signaling pathways in radioresistance
   Lei Chang et al, 2016, Oncotarget CrossRef
2. SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis
   XIAOFEN PAN et al, 2015, Oncology Reports CrossRef
3. Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
   Ya‐Ping Liu et al, 2021, MedComm CrossRef
4. Mitochondrial Metabolism: A New Dimension of Personalized Oncology
   Babak Behnam et al, 2023, Cancers CrossRef
5. Cytotoxic Autophagy in Cancer Therapy
   Khushboo Sharma et al, 2014, International Journal of Molecular Sciences CrossRef
6. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
   Beatrice Aramini et al, 2022, Cancers CrossRef
7. The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies
   Semer Maksoud, 2022, Molecular Neurobiology CrossRef
8. Silencing of ataxia-telangiectasia mutated by siRNA enhances the in vitro and in vivo radiosensitivity of glioma
   YAN LI et al, 2016, Oncology Reports CrossRef
9. Cisplatin-Resistant CD44+ Lung Cancer Cells Are Sensitive to Auger Electrons
   Karina Lindbøg Madsen et al, 2022, International Journal of Molecular Sciences CrossRef
10. Targeting protein kinases in cancer stem cells
    Stephanie Ma et al, 2022, Essays in Biochemistry CrossRef
11. Reactive Oxygen Species-Mediated Autophagy Defines the Fate of Cancer Stem Cells
    Matilde E. Lleonart et al, 2018, Antioxidants & Redox Signaling CrossRef
12. Cancer Stem Cells as Therapeutic Targets for Gastrointestinal Cancers
    Jyothi Priya Mandala et al, 2020, Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers CrossRef
13. The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo
    Sara Vaccaro et al, 2022, Frontiers in Pharmacology CrossRef
14. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo
    Yan Li et al, 2017, Oncology Reports CrossRef
15. Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma
    Chih-Jung Chen et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
16. AMPK/FOXO3a Pathway Increases Activity and/or Expression of ATM, DNA-PKcs, Src, EGFR, PDK1, and SOD2 and Induces Radioresistance under Nutrient Starvation
    Yusuke Urushihara et al, 2023, International Journal of Molecular Sciences CrossRef
17. Mechanisms of Cancer Resistance to Various Therapies
    Asiya Batool et al, 2024, Drug Resistance in Cancer: Mechanisms and Strategies CrossRef
18. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo
    Long Wang et al, 2015, Journal of Pharmacological Sciences CrossRef
19. Nowotworowe komórki macierzyste – im więcej wiemy, tym więcej pytań
    Karolina Zaleska et al, 2013, Zeszyty Naukowe WCO, Letters in Oncology Science CrossRef
20. Mathematical Modelling of Radiobiological Parameters
    Piernicola Pedicini et al, 2016, Radiobiology of Glioblastoma CrossRef
21. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study
    Hon-Yi Lin et al, 2015, Oncotarget CrossRef
22. Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance
    Katrien Konings et al, 2020, Frontiers in Oncology CrossRef
23. Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
    Farzad Taghizadeh-Hesary et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
24. Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
    Juliana B. Vilar et al, 2022, Cancers CrossRef
25. ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells
    Cyril Ronco et al, 2017, MedChemComm CrossRef